How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
How i-vbp® helped a specialty company pilot a new way to assess the value of targets for acquisition in multiple rare diseases CNS diseases Read More
How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD Read More
How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy Read More
How a thorough analysis of potential access scenarios allowed to successfully launch a new indication of a product Read More
How i-vbp enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy Read More
How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels Read More
How a deep-dive analysis of key analogues allowed for the development of focused recommendations to optimize long-term success for an advanced oncology product facing multiple indication expansions Read More
How focusing on the operational elements of pricing strategy supported in-country teams to strengthen their approach to pricing incremental innovation Read More
How the development of an international reference pricing model, supported by a deep understanding of market access dynamics, has supported launch sequencing of two specialty products Read More
How a deep understanding of pricing mechanisms in Japan enabled the formulation of a robust price estimate for a novel radiopharmaceutical Read More
How an innovative pricing calculator enabled the identification of key value drivers and compelling value metrics to support asset strategy Read More
How a semi-quantitative assessment of achievable pricing, combined with extensive input from global & affiliate colleagues, enabled the refinement of the global pricing strategy leading up to launch Read More
How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product Read More
How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders Read More
How creating a unified vision and comprehensive framework for Real-World Evidence (RWE) supported seamless execution of RWE projects Read More
How expert insights have helped gain a better understanding on the upcoming Joint Clinical Assessment in the EU and its challenges Read More
How developing a framework for Value Based Partnerships provided a platform for affiliates to explore how different tactics could be used to accelerate access Read More
How partnering with local experts helped define wave 3 of launch countries for our client’s geographical expansion Read More
How engaging with affiliates allowed for the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets Read More